Current study of pathogenetic mechanisms and therapeutics of chronic atrophic gastritis: a comprehensive review

Front Cell Dev Biol. 2024 Dec 10:12:1513426. doi: 10.3389/fcell.2024.1513426. eCollection 2024.

Abstract

Chronic atrophic gastritis (CAG) is a prevalent digestive system disease characterized by atrophy of the gastric mucosa and the disappearance of inherent gastric glands. According to the theory of Correa's cascade, CAG is an important pathological stage in the transformation from normal condition to gastric carcinoma. In recent years, the global incidence of CAG has been increasing due to pathogenic factors, including Helicobacter pylori infection, bile reflux, and the consumption of processed meats. In this review, we comprehensively described the etiology and clinical diagnosis of CAG. We focused on elucidating the regulatory mechanisms and promising therapeutic targets in CAG, with the expectation of providing insights and theoretical support for future research on CAG.

Keywords: biomarkers; chronic atrophic gastritis; gastric precancerous lesions; pathogenetic mechanisms; therapeutic targets.

Publication types

  • Review

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by Guangdong Medical University Research Foundation (4SG24205G, 4SG24257G), Discipline Construction Project of Guangdong Medical University (4SG24002G, 4SG21229GDGFY01), Dongguan Science and Technology of Social Development Program (20211800905542, 20231800939832), Guangdong Basic and Applied Basic Research Foundation-Yifang Pharmaceutical Joint Fund (2023A1515220233), Natural Science Foundation of Guangdong Province (2022A1515011302, 2023A1515011116) and Student Innovation Research and Entrepreneurship Training of Guangdong Medical University (GDMU2023144, GDMU2023109).